Functional properties of lymphocytes in idiopathic thrombocytopenic purpura

被引:54
作者
Webber, NP
Mascarenhas, JO
Crow, MK
Bussel, J
Schattner, EJ
机构
[1] Cornell Univ, Weill Med Coll, Div Hematol Oncol, Dept Pediat & Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA
关键词
idiopathic or immune thrombocytopenia; CD40; ligand; (CD40L; CD154); lymphocytes; cytokines; interteukin-4;
D O I
10.1016/S0198-8859(01)00348-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Idiopathic or immune thrombocytopenic purpura (ITP) is characterized by antibody-mediated destruction of platelets. The etiology is unknown. We postulated that increased autoantibody, production in ITP might be attributable to either increased or prolonged expression of CD40 ligand (CD40L, CD154) in T or B lymphocytes, as has been previously observed in systemic lupus erythematosus (SLE). In addition, we hypothesized that ITP is characterized by increased levels of interleukin 4 (IL-4), a prototypic Th2 cytokine,which, along with CD40 ligation, is required for B cell differentiation and production of several IgG subclasses. Cell surface CD154 expression was measured in freshly-isolated and in vitro-activated peripheral blood lymphocytes of sixteen ITP patients and eight healthy volunteers. Plasma levels of IL-4 and the prototypic Th1 cytokine interferon-gamma (IFN gamma) were determined. We observed that CD154 expression in unstimulated ind in vitro-activated lymphocytes did not differ between ITP patients and healthy controls. Plasma levels of the Th2 cytokine IL-4 were significantly, higher in the ITP patients. These studies indicate that overexpression of CD154 in lymphocytes is unlikely to be primary pathophysiological defect in most patients with ITP, The data support that in addition to cell membrane antigens Such is CD154, soluble cytokines such as IL-4 Should be considered as potential targets for therapy, in this disease. Human Immunology 62, 1346-1355 (2001). (C) American Society for Histocompatibility and Immunogenetics, 2001, Published by Elsevier Science Inc.
引用
收藏
页码:1346 / 1355
页数:10
相关论文
共 45 条
[1]   Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]  
ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671
[3]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[4]   CD4+ T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses [J].
Blazar, BR ;
Taylor, PA ;
Noelle, RJ ;
Vallera, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) :473-482
[5]  
Buhlmann JE, 1999, J IMMUNOL, V162, P4373
[6]  
Bussel J, 1999, BLOOD, V94, p646A
[7]   HUMAN-LYMPHOCYTES MAKING RHEUMATOID-FACTOR AND ANTIBODY TO SSDNA BELONG TO LEU-1+ B-CELL SUBSET [J].
CASALI, P ;
BURASTERO, SE ;
NAKAMURA, M ;
INGHIRAMI, G ;
NOTKINS, AL .
SCIENCE, 1987, 236 (4797) :77-81
[8]   CD5+ LYMPHOCYTE-B, POLYREACTIVE ANTIBODIES AND THE HUMAN B-CELL REPERTOIRE [J].
CASALI, P ;
NOTKINS, AL .
IMMUNOLOGY TODAY, 1989, 10 (11) :364-368
[9]   Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells [J].
Clodi, K ;
Asgary, Z ;
Zhao, SR ;
Kliche, KO ;
Cabanillas, F ;
Andreeff, M ;
Youns, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) :270-275
[10]  
Davis JC, 1999, ARTHRITIS RHEUM, V42, pS281